| |
| Table
Of Contents |
| |
| 1
INOTROPIC AGENTS |
| 2
ANTIARRHYTHMIC AGENTS |
| 3
BETA BLOCKERS |
| 4
CENTRALLY ACTING ANTIHYPERTENSIVE |
| 5
CA-CHANNEL BLOCKERS |
| 6
ACE INHIBITORS |
| 7
VASODILATORS |
| 8
ANGINA |
| 9
DIURETICS |
| 10
SPECIFIC ALPHA-1 BLOCKERS |
| |
| 11
ANTIHYPERLIPIDEMIC AGENTS |
| 12
TRANQUILIZERS |
| 13
ANTIEPILEPTICS |
| 14
ANTIDEPRESSANTS |
| 15
ANTIPARKINSONS |
| 16
ATTENTION DEFICIT DISORDER |
| 17
ANTINEUROLEPTICS |
| 18
ANTIBIOTICS |
| 19
ANTI AIDS |
| 20
ACNE PRODUCTS |
| |
| 21
ANORECTAL PRODUCTS |
| 22
PEPTIC ULCERS |
| 23
ANTIHISTAMINES |
| 24
APPETITE SUPPRESSANTS |
| 25
ARTHRITIS |
| 26
ASTHMA |
| 27
BPH |
| 28
COLONY & ERYTHROCYTE STIMULATORS |
| 29
HYPERURICEMIA & GOUT |
| 30
HEMATINIC AGENTS |
| |
| 31
IMMUNOSUPPRESSANTS |
| 32
MIGRAINES |
| 33
NAUSEA MEDICATIONS |
| 34
NONSTEROIDAL ANTIINFLAMMATORY AGENTS |
| 35
OPIOID ANALGESIC AGENTS |
| 36
OSTEOPOROSIS & HYPOCALCEMIA |
| 37
ANTIPLATELET AGENTS |
| 38
SMOKING CESSATION AGENTS |
| 39
THYROID DISEASE |
| 40
ULCERATIVE COLITIS |
| |
| 41
DIABETES |
| 42
EXPECTORANT & ANTITUSSIVE |
| 43
ACID BASE DISORDERS |
| 44
ORAL CONTRACEPTIVES |
| 45
ANTIGLAUCOMA |
| 46
CYSTIC FIBROSIS |
| 47
PSORIASIS |
| 48
PHARMACY LAW |
| 49
NEW DRUG APPROVAL |
| 50
CLINICAL DRUG LITERATURE |
| |
| 51
PHARMACOKINETIC |
| 52
VITAMINS AND THEIR SOURCES |
| 53
TERATOGENIC DRUGS |
| 54
TPN (TOTAL PARENTERAL NUTRITION) |
| 55
RENAL FAILURE |
| 56
INTERPRETATION OF CLINICAL LABORATORY TESTS |
| 57
DEMENTIA |
| 58
TUBERCULOSIS |
| 59
MULTIPLE SCLEROSIS |
| 60
MUSCLE RELAXANTS |
| |
| 61
HERBAL DRUGS |
| 62
CYTOTOXIC AGENTS |
| 63
IRRITABLE BOWEL SYNDROME AGENTS |
| 64
OPHTHALMIC AGENTS |
| 65
ANTINEOPLASTIC AGENTS |